ResMed Q4 Adj EPS $1.60 Misses $1.67 Estimate, Sales $1.122B Beat $1.12B Estimate
Portfolio Pulse from Benzinga Newsdesk
ResMed (NYSE:RMD) reported Q4 adjusted earnings of $1.60 per share, missing the analyst consensus estimate of $1.67 by 4.19%. However, the company's quarterly sales of $1.122 billion beat the estimate of $1.12 billion by 0.18%. Compared to the same period last year, earnings increased by 7.38% and sales increased by 22.66%.
August 04, 2023 | 2:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ResMed's Q4 earnings per share missed estimates, but sales beat expectations. Earnings and sales increased compared to the same period last year.
ResMed's earnings miss could negatively impact the stock price, but this may be offset by the sales beat and YoY growth in both earnings and sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100